Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...

Swiss biotech BioVersys, which develops treatments for serious infections caused by drug resistant bacteria, has completed its initial public offering with an implied market valuation of 213 million ...

Ltd., Thermo Fisher Scientific Inc., and Vertex Pharmaceuticals Inc. The biotech market is experiencing significant growth with trends such as genetic engineering and precision medicine leading ...

The biotech sector in 2025 presents a landscape brimming with both opportunities and challenges. The industry is being shaped ...

Regeneron Pharmaceuticals Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., Thermo Fisher Scientific Inc., and Vertex Pharmaceuticals Inc. The biotech market is experiencing significant growth with ...

Government measures are expected to challenge pharmaceutical firms. Australia’s pharmaceutical market is projected to expand ...

The Biotechnology Market report delivers crucial insights into the market's growth trajectory and the primary revenue drivers anticipated between 2025 and 2034. As industries undergo transformation ...

This week’s episode of The Top Line dives into the discussion, featuring Fierce Biotech’s Gabrielle Masson ... biotechs that debuted on the public market in 2024, the keys to success for ...

Of the 102 company launches or series A financings since October 2023, just nine had a woman at the helm, according to a ...